Dalaré Eye PN 1%

Korean injectable PN 1% skin booster in development for targeted eye-area rejuvenation.

Dalaré Eye PN 1% is an injectable polynucleotide skin booster under development by ESTHÉCOR for targeted eye-area rejuvenation. Conceptualised in Seoul and manufactured in Korea, it forms part of the Dalaré PN and HA collection.
Featuring a 1% PN formulation in a 2 mL syringe, Dalaré Eye PN 1% is being developed with a focus on the delicate periorbital area and the appearance of fine lines and skin texture. Its formulation combines polynucleotides with water, sodium chloride and phosphate buffers, without added hyaluronic acid or lidocaine.

As the eye-focused variant within the collection, it is being developed for a distinct treatment context. Its suitability, dose and administration technique require assessment specific to the product and treatment area; a lower PN concentration alone does not establish suitability around the eyes.

Inspired by the Korean expression “under the moon”, Dalaré embodies “Korean Beauty, Refined Under the Moon”—a philosophy of calm, considered care.

The injectable medical-device version is in development, with final indications and market availability subject to validation and applicable regulatory requirements. Meet ESTHÉCOR at CCR London to explore the collection and discuss future partnerships.